Table 2 |
||||||||
|
Comparison of breast cancer events in prospective randomized trials of DCIS treatment |
||||||||
| EORTC 10853 [13] |
NSABP B17 [11] |
SWE DCIS [24] |
UK/ANZ DCIS [15] |
|||||
|
|
||||||||
| 4 y follow up |
4 follow up |
5.2 follow up |
4.3 y follow-up |
|||||
|
|
||||||||
| L |
L+RT |
CL |
L+RT |
L |
L+RT |
L |
L +RT |
|
|
|
||||||||
| Type of cancer |
(n = 503) |
(n = 507) |
(n = 403) |
(n = 410) |
(n = 533) |
(n = 534) |
(n = 544) |
(n = 267) |
| Ipsilateral breast cancer |
||||||||
| Total |
83 |
53 |
98 |
49 |
117 |
44 |
115 |
22 |
| Invasive |
40 |
24 |
66 |
29 |
69 |
23 |
39 |
10 |
| No invasive |
44 |
29 |
32 |
20 |
48 |
21 |
76 |
12 |
| Contralateral Breast cancer |
||||||||
| Total |
8 |
21 |
8 |
10 |
22 |
26 |
11 |
9 |
| Invasive |
5 |
16 |
5 |
8 |
15 |
23 |
6 |
9 |
| No invasive |
3 |
5 |
3 |
2 |
7 |
3 |
5 |
0 |
|
L = Lumpectomy, RT = radiotherapy | ||||||||
Viani et al. Radiation Oncology 2007 2:28 doi:10.1186/1748-717X-2-28 |
||||||||
